4-Bromo-1,1,3,3,5,5,7,7-octaethyl-1,2,3,5,6,7-hexahydro-s-indacene, 95%, 1g

N-(4-Fluorophenethyl)-4-(4-methyl-7-oxo-2-(p-tolyl)-2H-pyrazolo[3,4-d]pyridazin-6(7H)-yl)butanamide, 98.0%, 100mg

Narrow mouth bottle ROTILABO® with screw cap, 500 ml, 6 Piece(s)

Plan PL S100x/1.25 objective. Working distance 0.33 mm

1-(2-chlorobenzoyl)-1,4-diazepane, 95.0%, 2g

(R)-3-(TERT-BUTYL)-4-(2,6-DIMETHOXY-3,5-DIMETHYLPHENYL)-2,3-DIHYDROBENZO[D][1,3]OXAPHOSPHOLE, 95%, 500mg

Fmoc-(S)-3-amino-3-(2-trifluoromethylphenyl)-propionic acid, 97%, 250mg

(S)-BENZYL 2-(HYDROXYMETHYL)PIPERIDINE-1-CARBOXYLATE, 95.0%, 100mg

1-(Adamantan-1-yl)ethanol, 95.0%, 1g

5-Bromo-3-(trifluoromethyl)picolinaldehyde, 95.0%, 5g

(R,E)-5-([1,1'-Biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpent-2-enoic acid, 97.0%, 100g

4-methoxy-6-methyl-pyridin-2-amine, 95, 1g

tert-Butyl (2-(2-(2-(2-bromoethoxy)ethoxy)ethoxy)ethyl)carbamate, 97.0%, 1g